The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profiles
Open accessAbstract
Alzheimer’s disease (AD) is heterogenous at the molecular level. Understanding this heterogeneity is critical for AD drug development. Here we define AD molecular subtypes using mass spectrometry proteomics in cerebrospinal fluid, based on 1,058 proteins, with different levels in individuals with AD (n = 419) compared to controls (n = 187). These AD subtypes had alterations in protein levels that were associated with distinct molecular processes: subtype 1 was characterized by proteins related to neuronal hyperplasticity; subtype 2 by innate immune activation; subtype 3 by RNA dysregulation; subtype 4 by choroid plexus dysfunction; and subtype 5 by blood–brain barrier impairment. Each subtype was related to specific AD genetic risk variants, for example, subtype 1 was enriched with TREM2 R47H. Subtypes also differed in clinical outcomes, survival times and anatomical patterns of brain atrophy. These results indicate molecular heterogeneity in AD and highlight the need for personalized medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Pericyte loss influences Alzheimer-like neurodegeneration in mice
Sagare, A. P., Bell, R. D., Zhao, Z., Ma, Q., Winkler, E. A., Ramanathan, A., & Zlokovic, B. V. (2013) · Nature Communications · doi:10.1038/ncomms3932 · Cited by 589
RetractedFischl, B. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.01.021 · Cited by 9,526
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
Chen, E. Y., Tan, C. M., Kou, Y., Duan, Q., Wang, Z., Meirelles, G. V., Clark, N. R., & Ma’ayan, A. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-128 · Cited by 7,814
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Nichols, E., Steinmetz, J. D., Vollset, S. E., Fukutaki, K., Chalek, J., Abd-Allah, F., Abdoli, A., Abualhasan, A., Abu-Gharbieh, E., Akram, T. T., et al. (2022) · The Lancet Public Health · doi:10.1016/s2468-2667(21)00249-8 · Cited by 5,575
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343 · cited 2×
“Neuroimmune signaling occurs during normal neuronal development when microglia prune immature synapses 53–55 .”
BackgroundLong Noncoding RNA as Modular Scaffold of Histone Modification Complexes
Tsai, M.-C., Manor, O., Wan, Y., Mosammaparast, N., Wang, J. K., Lan, F., Shi, Y., Segal, E., & Chang, H. Y. (2010) · Science · doi:10.1126/science.1192002 · Cited by 3,290 · cited 1×
“1d and Supplementary Table 7) and SUZ12 ( P adjusted = 0.016 × 10 −12 ), which regulate plasticity-related processes through repression of neuronal differentiation genes 30,31 .”
BackgroundInfluentialNeurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Research works printed but not linked: 57
- Hondius, D. C. et al. Profiling the human hippocampal proteome at all pathologic stages of Alzheimer’s disease. Alzheimers Dement. 12, 654–668 (2016). · DOI · Paper page
- Caldwell, A. B. et al. Transcriptomic profiling of sporadic Alzheimer’s disease patients. Mol. Brain 15, 83 (2022). · DOI
- Tijms, B. M. et al. Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomics. Brain 143, 3776–3792 (2020). · DOI · Paper page
- Haeberlein, S. B. et al. Two randomized phase 3 studies of aducanumab in early Alzheimer’s disease. J. Prev. Alzheimers Dis. 9, 197–210 (2022).
- van Dyck, C. H. et al. Lecanemab in early Alzheimer’s disease. N. Engl. J. Med. 388, 9–21 (2022). · DOI · Paper page
- Visser, P. J. et al. Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease. Mol. Neurodegener. 17, 27 (2022). · DOI
- Tijms, B. M. et al. CSF proteomic Alzheimer’s disease-predictive subtypes in cognitively intact amyloid negative individuals. Proteomes 9, 36 (2021). · DOI
- van der Flier, W. M. et al. Optimizing patient care and research: the Amsterdam Dementia Cohort. J. Alzheimers Dis. 41, 313–327 (2014). · DOI · Paper page
- Konijnenberg, E. et al. The EMIF-AD PreclinAD study: study design and baseline cohort overview. Alzheimers Res. Ther. 10, 85 (2018). · DOI
- Legdeur, N. et al. Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ study. BMC Geriatr. 18, 289 (2018). · DOI
- Ritchie, C. W. et al. The European Prevention of Alzheimer’s Dementia (EPAD) longitudinal cohort study: baseline data release V500.0. J. Prev. Alzheimers Dis. 7, 8–13 (2020).
- de Leon, M. J. et al. The nonlinear relationship between cerebrospinal fluid Aβ42 and tau in preclinical Alzheimer’s disease. PLoS ONE 13, e0191240 (2018). · DOI
- Lee, D. D. & Seung, H. S. Learning the parts of objects by non-negative matrix factorization. Nature 401, 788–791 (1999). · DOI · Paper page
- Karch, C. M., Jeng, A. T. & Goate, A. M. Extracellular tau levels are influenced by variability in tau that is associated with tauopathies. J. Biol. Chem. 287, 42751–42762 (2012). · DOI · Paper page
- Yamada, K. et al. Neuronal activity regulates extracellular tau in vivo. J. Exp. Med. 211, 387–393 (2014). · DOI · Paper page
- Kaeser, S. A. et al. CSF p-tau increase in response to Aβ-type and Danish-type cerebral amyloidosis and in the absence of neurofibrillary tangles. Acta Neuropathol. 143, 287–290 (2022). · DOI
- Ballas, N. & Mandel, G. The many faces of REST oversee epigenetic programming of neuronal genes. Curr. Opin. Neurobiol. 15, 500–506 (2005). · DOI · Paper page
- Lu, T. et al. REST and stress resistance in ageing and Alzheimer’s disease. Nature 507, 448–454 (2014). · DOI · Paper page
- Sadleir, K. R. et al. Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer’s disease. Acta Neuropathol. 132, 235–256 (2016). · DOI · Paper page
- Cosker, K. et al. Microglial signalling pathway deficits associated with the patient derived R47H TREM2 variants linked to AD indicate inability to activate inflammasome. Sci. Rep. 11, 13316 (2021). · DOI
- Zhao, R., Hu, W., Tsai, J., Li, W. & Gan, W.-B. Microglia limit the expansion of β-amyloid plaques in a mouse model of Alzheimer’s disease. Mol. Neurodegener. 12, 47 (2017). · DOI · Paper page
- Yuan, P. et al. TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron 90, 724–739 (2016). · DOI · Paper page
- Stoiljkovic, M., Gutierrez, K. O., Kelley, C., Horvath, T. L. & Hajós, M. TREM2 deficiency disrupts network oscillations leading to epileptic activity and aggravates amyloid-β-related hippocampal pathophysiology in mice. J. Alzheimers Dis. 88, 837–847 (2022). · DOI
- Hu, B. et al. Insights into the role of CSF1R in the central nervous system and neurological disorders. Front. Aging Neurosci. 13, 789834 (2021). · DOI
- Tábuas-Pereira, M., Santana, I., Guerreiro, R. & Brás, J. Alzheimer’s disease genetics: review of novel loci associated with disease. Curr. Genet. Med. Rep. 8, 1–16 (2020). · DOI
- Geuens, T., Bouhy, D. & Timmerman, V. The hnRNP family: insights into their role in health and disease. Hum. Genet. 135, 851–867 (2016). · DOI · Paper page
- Kavanagh, T., Halder, A. & Drummond, E. Tau interactome and RNA binding proteins in neurodegenerative diseases. Mol. Neurodegener. 17, 66 (2022). · DOI · Paper page
- Sidhu, R., Gatt, A., Fratta, P., Lashley, T. & Bampton, A. HnRNP K mislocalisation in neurons of the dentate nucleus is a novel neuropathological feature of neurodegenerative disease and ageing. Neuropath. Appl. Neurobiol. 48, e12793 (2022). · DOI
- Yu, Q.-S., Feng, W.-Q., Shi, L.-L., Niu, R.-Z. & Liu, J. Integrated analysis of cortex single-cell transcriptome and serum proteome reveals the novel biomarkers in Alzheimer’s disease. Brain Sci. 12, 1022 (2022). · DOI
- Moore, D. L. et al. KLF family members regulate intrinsic axon regeneration ability. Science 326, 298–301 (2009). · DOI · Paper page
- Wei, Y. et al. Multiple direct interactions of TBP with the MYC oncoprotein. Nat. Struct. Mol. Biol. 26, 1035–1043 (2019). · DOI
- Majd, S., Power, J. & Majd, Z. Alzheimer’s disease and cancer: when two monsters cannot be together. Front. Neurosci. 13, 155 (2019). · DOI
- Tan, M.-S., Yu, J.-T. & Tan, L. Bridging integrator 1 (BIN1): form, function, and Alzheimer’s disease. Trends Mol. Med. 19, 594–603 (2013). · DOI · Paper page
- Damián-Zamacona, S. et al. Cell survival regulation during receptor-mediated endocytosis of chemically-modified lipoproteins associated to the formation of an Amphiphysin 2 (Bin1)/c-Myc complex. Biochem. Bioph. Res. Commun. 505, 365–371 (2018). · DOI
- Mehta, P. R., Brown, A.-L., Ward, M. E. & Fratta, P. The era of cryptic exons: implications for ALS-FTD. Mol. Neurodegener. 18, 16 (2023). · DOI
- Liddelow, S. A. Development of the choroid plexus and blood–CSF barrier. Front. Neurosci. 9, 32 (2015). · DOI · Paper page
- Serot, J.-M., Béné, M.-C., Foliguet, B. & Faure, G. C. Morphological alterations of the choroid plexus in late-onset Alzheimer’s disease. Acta Neuropathol. 99, 105–108 (2000). · DOI · Paper page
- Čarna, M. et al. Pathogenesis of Alzheimer’s disease: involvement of the choroid plexus. Alzheimers Dement. 19, 3537–3554 (2023). · DOI
- Cui, J. et al. Inflammation of the embryonic choroid plexus barrier following maternal immune activation. Dev. Cell 55, 617–628 (2020). · DOI · Paper page
- Bossaerts, L., Cacace, R. & Van Broeckhoven, C. The role of ATP-binding cassette subfamily A in the etiology of Alzheimer’s disease. Mol. Neurodegener. 17, 31 (2022). · DOI
- Chitu, V., Gokhan, Ş., Nandi, S., Mehler, M. F. & Stanley, E. R. Emerging roles for CSF-1 receptor and its ligands in the nervous system. Trends Neurosci. 39, 378–393 (2016). · DOI · Paper page
- Zuroff, L. R. et al. Effects of IL-34 on macrophage immunological profile in response to Alzheimer’s-related Aβ42 assemblies. Front. Immunol. 11, 1449 (2020). · DOI
- Garcia, F. J. et al. Single-cell dissection of the human brain vasculature. Nature 603, 893–899 (2022). · DOI · Paper page
- Tomassen, J. et al. Abnormal cerebrospinal fluid levels of amyloid and tau are associated with cognitive decline over time in cognitively normal older adults: a monozygotic twin study. Alzheimers Dements 8, e12346 (2022).
- Tijms, B. M. et al. Unbiased approach to counteract upward drift in cerebrospinal fluid amyloid-β 1–42 analysis results. Clin. Chem. 64, 576–585 (2018). · DOI · Paper page
- Mulder, C. et al. Amyloid-β(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease. Clin. Chem. 56, 248–253 (2010). · DOI · Paper page
- Ingala, S. et al. Application of the ATN classification scheme in a population without dementia: findings from the EPAD cohort. Alzheimers Dement 17, 1189–1204 (2021). · DOI
- Willemse, E. A. J. et al. Diagnostic performance of Elecsys immunoassays for cerebrospinal fluid Alzheimer’s disease biomarkers in a nonacademic, multicenter memory clinic cohort: the ABIDE project. Alzheimers Dement. 10, 563–572 (2018).
- Wesenhagen, K. E. J. et al. P-tau subgroups in AD relate to distinct amyloid production and synaptic integrity profiles. Alzheimers Res. Ther. 14, 95 (2022). · DOI
- Dicks, E. et al. Gray matter network measures are associated with cognitive decline in mild cognitive impairment. Neurobiol. Aging 61, 198–206 (2018). · DOI
- Legdeur, N. et al. Associations of brain pathology, cognitive and physical markers with age in cognitively normal individuals aged 60–102 years. J. Gerontol. A Biol. Sci. Med. Sci 75, 1609–1617 (2020). · DOI
- Lorenzini, L. et al. The Open-Access European Prevention of Alzheimer’s Dementia (EPAD) MRI dataset and processing workflow. Neuroimage Clin. 35, 103106 (2022). · DOI
- Plubell, D. L. et al. Extended multiplexing of tandem mass tags (TMT) labeling reveals age and high fat diet specific proteome changes in mouse epididymal adipose tissue. Mol. Cell. Proteomics 16, 873–890 (2017). · DOI · Paper page
- Rouillard, A. D. et al. The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins. Database 2016, baw100 (2016). · DOI · Paper page
- Otero-Garcia, M. et al. Molecular signatures underlying neurofibrillary tangle susceptibility in Alzheimer’s disease. Neuron 110, 2929–2948 (2022). · DOI · Paper page
- Modeste, E. S. et al. Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer’s disease. Mol. Neurodegener. 18, 48 (2023). · DOI
- Dammer, E. B. et al. Multi-platform proteomic analysis of Alzheimer’s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome. Alzheimers Res. Ther. 14, 174 (2022). · DOI · Paper page
Cited by
Valotto Neto, L. J., Reverete de Araujo, M., Moretti Junior, R. C., Mendes Machado, N., Joshi, R. K., dos Santos Buglio, D., Barbalho Lamas, C., Direito, R., Fornari Laurindo, L., Tanaka, M., et al. (2024) · Antioxidants · doi:10.3390/antiox13040393 · Cited by 146
Ren, F., Wei, J., Chen, Q., Hu, M., Yu, L., Mi, J., Zhou, X., Qin, D., Wu, J., & Wu, A. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.07.030 · Cited by 97
Ali, M., Timsina, J., Western, D., Liu, M., Beric, A., Budde, J., Do, A., Heo, G., Wang, L., Gentsch, J., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.02.014 · Cited by 61
Large‐scale deep proteomic analysis in Alzheimer's disease brain regions across race and ethnicity
Seifar, F., Fox, E. J., Shantaraman, A., Liu, Y., Dammer, E. B., Modeste, E., Duong, D. M., Yin, L., Trautwig, A. N., Guo, Q., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.14360 · Cited by 52
Crosstalk between bone and brain in Alzheimer's disease: Mechanisms, applications, and perspectives
Liu, Z., Liu, M., Xiong, Y., Wang, Y., & Bu, X. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13864 · Cited by 39
Metadata
- Authors
- Tijms, B. M., Vromen, E. M., Mjaavatten, O., Holstege, H., Reus, L. M., van der Lee, S., Wesenhagen, K. E. J., Lorenzini, L., Vermunt, L., Venkatraghavan, V., Tesi, N., Tomassen, J., den Braber, A., Goossens, J., Vanmechelen, E., Barkhof, F., Pijnenburg, Y. A. L., van der Flier, W. M., Teunissen, C. E., Berven, F. S., & Visser, P. J.
- Venue
- Nature Aging
- Published
- 2024-01-09
- Volume
- 4
- Issue
- 1
- Pages
- 33-47
- ISSN
- 2662-8465 (ISSN-L)
- OpenAlex
- W4390706250
- Cited by
- 202
- References
- 60
- FWCI
- 48.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Funders
- ZonMw (733050824)
- the Dutch L’Óreal-UNESCO fellowship 2022 for women in science
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profiles. https://app.cochat.ai/papers/10.1038/s43587-023-00550-7
- The paper
- Tijms, B. M., Vromen, E. M., Mjaavatten, O., Holstege, H., Reus, L. M., van der Lee, S., Wesenhagen, K. E. J., Lorenzini, L., Vermunt, L., Venkatraghavan, V., Tesi, N., Tomassen, J., den Braber, A., Goossens, J., Vanmechelen, E., Barkhof, F., Pijnenburg, Y. A. L., van der Flier, W. M., Teunissen, C. E., . . . Visser, P. J. (2024). Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profiles. Nature Aging. https://doi.org/10.1038/s43587-023-00550-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.